James Basta News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Intellia Therapeutics, Inc (NASDAQ:NTLA) Shares Sold by Contrarius Investment Management Ltd

Contrarius Investment Management Ltd decreased its holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 7.5% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 214,401 shares of the company’s stock after selling 17,461 shares during the quarter. Contrarius Investment Management Ltd owned […]

New zealand generalNew zealandJames bastaWolfe researchHermes incCanaccord genuity groupIntellia therapeutics incWellington management groupInvestment managementContrarius investment management ltdDimensional fund advisorsGoldman sachs groupIntellia therapeuticsFree reportInvestment management ltdManagement group

Intellia Therapeutics (NASDAQ:NTLA) Raised to Sell at StockNews com

Intellia Therapeutics (NASDAQ:NTLA) Raised to Sell at StockNews com
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

James bastaIntellia therapeutics company profileIntellia therapeutics incChina universal asset management coWolfe researchDaiwa securities group incBlue trust incGoldman sachs groupIntellia therapeuticsFree reportModerate buyGet free reportUniversal asset managementSecurities groupSpire wealth managementWealth management

BMO Capital Markets Increases Intellia Therapeutics (NASDAQ:NTLA) Price Target to $70 00

BMO Capital Markets Increases Intellia Therapeutics (NASDAQ:NTLA) Price Target to $70 00
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

James bastaIntellia therapeutics incInterchange capital partnersVanguard group incHeadlands technologiesCanaccord genuity groupSageview advisory groupProshare advisorsSecurities exchange commissionWolfe researchGoldman sachs groupIntellia therapeuticsGet free reportTherapeutics trading downExchange commissionView advisory group

New York State Common Retirement Fund Acquires 4,765 Shares of Intellia Therapeutics, Inc (NASDAQ:NTLA)

New York State Common Retirement Fund Acquires 4,765 Shares of Intellia Therapeutics, Inc (NASDAQ:NTLA)
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesJames bastaYork state common retirement fundExchange commissionWolfe researchSecurities exchange commissionInvestment managementGoldman sachs groupHermes incIntellia therapeutics incCanaccord genuity groupIntellia therapeutics company profileSumitomo mitsui trust holdings incNew york state common retirement fundIntellia therapeutics

BMO Capital Markets Raises Intellia Therapeutics (NASDAQ:NTLA) Price Target to $70 00

BMO Capital Markets Raises Intellia Therapeutics (NASDAQ:NTLA) Price Target to $70 00
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Zurcher kantonalbank zurich cantonalbankJames bastaWolfe researchRaymond james associatesMirae asset global investments coGoldman sachs groupCommonwealth equity servicesCanaccord genuity groupRaymond james financial services advisors incIntellia therapeutics incIntellia therapeuticsGet free reportGenuity groupEquity servicesJames financial services advisorsKantonalbank zurich cantonalbank